Novozymes, Inc.
44 articles about Novozymes, Inc.
-
Novozymes delivers historically strong full-year results
1/26/2023
In the 2022 financial year, Novozymes delivers 9% organic sales growth – 11% organic sales growth in the fourth quarter alone – an EBIT-margin before special items[*] of 26.4%, and ROIC including goodwill before special items* of 17.9%.
-
Novozymes and LinusBio announce collaboration to accelerate scientific discovery in Biohealth
11/10/2022
Novozymes, the world leader in biological solutions, and LinusBio, a leader in precision exposome sequencing, announced the companies are forming a collaboration to test a new, non-invasive technology in a clinical trial.
-
Novozymes confirms upgraded guidance by strong start to Q4
11/3/2022
In the first nine months of the 2022 financial year, Novozymes delivers 9% organic sales growth, an EBIT-margin of 27.2%, and ROIC including goodwill of 17.8%.
-
Novozymes delivers strong half year results and narrows full-year outlook upwards
8/11/2022
Novozymes delivers 10% organic sales growth and an EBIT-margin of 26% in the first half of the year, with 18% organic sales growth in DKK.
-
Novozymes and AgroFresh to explore development of biological solutions to combat post-harvest waste
6/15/2022
Novozymes, the leading biotech powerhouse, and AgroFresh, a global leader in post-harvest freshness solutions, are forming a research and commercialization partnership towards developing biological solutions that can improve post-harvest food quality and minimize waste by fighting fungal pathogens.
-
Novozymes announces plan to increase prices to cover rising cost of raw materials, energy, and logistics
3/31/2022
Novozymes announces its plan to pass on the incurred increase in raw material, energy, and logistics costs to its customers across geographies and industries.
-
Novozymes delivers strong 2021 full-year results and expects continued, solid progress in 2022
2/1/2022
In the 2021 financial year, Novozymes delivers 6% organic sales growth – 7% organic sales growth in the fourth quarter alone – an EBIT-margin of 26.8%, and ROIC including goodwill of 19.3%.
-
Novozymes delivers strong Q2 results and narrows full-year guidance to the high-end of the range
8/12/2021
Novozymes delivered 9% organic sales growth in the second quarter and 6% organic sales growth in the first half of 2021. The company has narrowed its full-year financial guidance from previously 2-6% and now expects organic sales growth of 4-6% and an EBIT margin of ~26%, from previously 25-26%.
-
Carbios Enters Joint Development Agreement With Novozymes to Produce Its Proprietary Enzyme for Complete Recycling of PET-plastics and Fibers
1/30/2020
CARBIOS, a company pioneering new bio-industrial solutions to reinvent the lifecycle of plastic and textile polymers, announced an exclusive partnership with leading biological solutions company, Novozymes.
-
Riffyn Enters Multi-Year Contract with Novozymes for R&D Data Analytics
6/5/2019
In the past two years, Novozymes has realized significant benefits to its R&D capabilities and outcomes
-
Elanco Announces Collaboration Agreement with Novozymes for Nutritional Health Innovation
11/2/2018
The collaboration furthers Elanco’s commitment to antibiotic stewardship and offering alternatives to unmet needs.
-
In a survey of more than 8,000 people in the biotech and pharma industry for Science, Regeneron Pharmaceuticals, topped the list.
-
EBD Group: Global life sciences to convene in Copenhagen for Europe's largest annual biopharma partnering conference
8/30/2018
The 24th annual BIO-EUROPE (R) 2018 Global Life Science Partnership event will be held November 5-7, 2018, in Copenhagen, Denmark.
-
Riffyn Forms Advisory Board of Biopharm and Biotech R&D Innovators
5/31/2018
Mr. Falholt previously served as the head of Novozymes R&D. Mr. Deshmukh most recently served as the Executive Director of R&D IT at Merck Sharp & Dohme.
-
Novozymes Release: Changes to the Executive Leadership Team
12/20/2017
Novozymes announces the appointment of Ms. Prisca Havranek-Kosicek as new CFO effective February 1, 2018.
-
Novozymes: Proposal of Candidates to the Board of Directors
12/11/2017
The Board of Directors has today decided to propose the following candidates for the Board of Directors for election on March 13, 2018 for a one-year term:
-
Novozymes, Inc. Is Ranked The Best Science Employer In The World
10/30/2015
-
Novozymes, Inc. 9M Sales And Profit In Line With August Expectations; Full-Year Outlook Narrowed
10/22/2015
-
Novozymes, Inc. Sees Positive Outlook For 2015, Sets New Long-Term Targets
1/20/2015
-
Novozymes, Inc. Release: Partnering For Impact
1/20/2015